Leonenko Zoya, Gill Simardeep, Baoukina Svetlana, Monticelli Luca, Doehner Jana, Gunasekara Lasantha, Felderer Florian, Rodenstein Mathias, Eng Lukas M, Amrein Matthias
Department of Cell Biology and Anatomy, Faculty of Medicine, Faculty of Science, University of Calgary, Calgary, Alberta, Canada.
Biophys J. 2007 Jul 15;93(2):674-83. doi: 10.1529/biophysj.107.106310. Epub 2007 May 4.
In adult respiratory distress syndrome, the primary function of pulmonary surfactant to strongly reduce the surface tension of the air-alveolar interface is impaired, resulting in diminished lung compliance, a decreased lung volume, and severe hypoxemia. Dysfunction coincides with an increased level of cholesterol in surfactant which on its own or together with other factors causes surfactant failure. In the current study, we investigated by atomic force microscopy and Kelvin-probe force microscopy how the increased level of cholesterol disrupts the assembly of an efficient film. Functional surfactant films underwent a monolayer-bilayer conversion upon contraction and resulted in a film with lipid bilayer stacks, scattered over a lipid monolayer. Large stacks were at positive electrical potential, small stacks at negative potential with respect to the surrounding monolayer areas. Dysfunctional films formed only few stacks. The surface potential of the occasional stacks was also not different from the surrounding monolayer. Based on film topology and potential distribution, we propose a mechanism for formation of stacked bilayer patches whereby the helical surfactant-associated protein SP-C becomes inserted into the bilayers with defined polarity. We discuss the functional role of the stacks as mechanically reinforcing elements and how an elevated level of cholesterol inhibits the formation of the stacks. This offers a simple biophysical explanation for surfactant inhibition in adult respiratory distress syndrome and possible targets for treatment.
在成人呼吸窘迫综合征中,肺表面活性剂降低气-肺泡界面表面张力的主要功能受损,导致肺顺应性降低、肺容积减小和严重低氧血症。功能障碍与表面活性剂中胆固醇水平升高同时出现,胆固醇自身或与其他因素共同导致表面活性剂功能衰竭。在本研究中,我们通过原子力显微镜和开尔文探针力显微镜研究了胆固醇水平升高如何破坏高效膜的组装。功能性表面活性剂膜在收缩时经历单层-双层转变,形成由脂质双层堆叠组成的膜,散布在脂质单层上。相对于周围的单层区域,大的堆叠具有正电势,小的堆叠具有负电势。功能失调的膜仅形成少量堆叠。偶尔形成的堆叠的表面电势与周围的单层也没有差异。基于膜拓扑结构和电势分布,我们提出了一种堆叠双层斑块形成的机制,即螺旋状表面活性剂相关蛋白SP-C以特定极性插入双层中。我们讨论了堆叠作为机械增强元件的功能作用以及胆固醇水平升高如何抑制堆叠的形成。这为成人呼吸窘迫综合征中表面活性剂抑制提供了一个简单的生物物理解释以及可能的治疗靶点。